Sofia, Bulgaria, September 20, 2021 - According to art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on September 17, 2021 the Company bought 200 000 own shares representing 0.1484% of the share capital of the Company, at a total value of BGN 740 000 on the Bulgarian Stock Exchange, the average price per share was 3.700 BGN.
The total number of treasury shares after this transaction is 9 811 467, representing 7.279% of the share capital of the Company.
Sofia, Bulgaria, September 16, 2021 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of September 16, 2021, “Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows: